42 A NOVEL VECTORIZED HCV THERAPEUTIC VACCINE (TG4040): RESULTS OF A PHASE I STUDY IN NAIVE PATIENTS CHRONICALLY INFECTED BY HCV
F. Habersetzer, J.-P. Zarski, V. Leroy, M. Maynard-Muet, J.-P. Bronowicki, C. Feray, C. Hézode, A. Fournillier, C. Bain, G. Inchauspé, G. Honnet, C. TrépoVolume:
50
Year:
2009
Language:
english
DOI:
10.1016/s0168-8278(09)60044-1
File:
PDF, 47 KB
english, 2009